TrialBritish journal of cancer2008

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.

D Generali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.